Abdulkareem NM, Jiang Y, Qi Y, Liu X, et al. Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansion. Proc Natl Acad Sci U S A 2026;123:e2513742123.
PMID: 41961819